Filing Flows › Health Care › Positron (POSC)
Positron (POSC) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Aug 14, 2026 · Positron (POSC) Q2 2026 earnings results →
Q2 2026 Revenue down 7% year over year to $112K · 735¢ of every $1 of revenue lost · operating margin -718.9%
Positron made $112K in Q2 2026 (-7% Y/Y). Operating margin -718.9%, net loss $821K. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 14, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $112K in Q2 2026, down 7% year over year and up 1% from the previous quarter.
Operating costs exceeded revenue by $804K, an operating margin of -718.9%. Total costs fell 29% while revenue fell 7%. The quarter ended with a net loss of $821K, narrower than the previous quarter's $1.4M loss.
Operating cash flow was −$1.0M. Non-cash charges added back $10K of depreciation. Working capital and other items used $238K.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Aug 14, 2026 | $112K | -7% | -718.9% | −$821K | −$1.0M |
| Q1 2026 | 10-Q | May 15, 2026 | $111K | -7% | n/m | −$1.4M | −$789K |
| Q3 2015 | 10-Q | Nov 23, 2015 | $304K | -23% | -55.9% | −$255K | −$48K |
| Q2 2015 | 10-Q | Aug 14, 2015 | $328K | -8% | -68.0% | −$375K | −$161K |
| Q1 2015 | 10-Q | May 15, 2015 | $346K | -24% | -153.5% | −$554K | −$336K |
| Q4 2014 | 10-K | Mar 31, 2015 | $259K | -46% | -248.6% | $86K | −$532K |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Positron
Positron Corporation (the “Company” or “Positron”) was incorporated under the laws of the State of Texas in 1983. Unless the context requires otherwise, in this report the terms “we,” “us”, “our”, “the Company”, and “Positron” refer to Positron Corporation. Positron Corporation was incorporated as a Texas corporation in 1983 with its corporate headquarters in North Tonawanda, New York.
In its own words, from its 10-K, filed Mar 31, 2026.
Positron against its Electromedical & Electrotherapeutic Apparatus peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: -7% against the peers' median +14%. Operating margin: -718.9% against the peers' median 6.3%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| POSC Positron | Q2 2026 | $112K | -7% | -718.9% |
| MDT Medtronic | Q1 FY27 | $9.8B | +14% | 18.1% |
| ITGR Integer Holdings | Q3 2026 | $450M | -4% | 6.3% |
| LIVN LivaNova | Q3 2026 | $393M | +10% | 7.2% |
| CNMD Conmed | Q3 2026 | $336M | -0.7% | 11.1% |
| TMDX TransMedics Group | Q3 2026 | $203M | +41% | 13.9% |
| AXGN Axogen | Q3 2026 | $75.8M | +26% | 1.3% |
| OM Outset Medical | Q3 2026 | $33.6M | +14% | -36.5% |
| CBLL Ceribell | Q3 2026 | $29.3M | +30% | -70.0% |
Source: Positron 10-Q on SEC EDGAR · CIK 844985 · Electromedical & Electrotherapeutic Apparatus
More on POSC
History
Every quarter: Q2 2026 results · Q1 2026 results · Q3 2015 results · Q2 2015 results · Q1 2015 results · Q4 2014 results